Market revenue in 2024 | USD 1,933.5 million |
Market revenue in 2030 | USD 3,640.2 million |
Growth rate | 11.1% (CAGR from 2025 to 2030) |
Largest segment | Chemotherapy |
Fastest growing segment | Immunotherapy |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Other |
Key market players worldwide | Pfizer Inc, Eli Lilly and Co, AstraZeneca PLC, Bristol-Myers Squibb Co, Boehringer Ingelheim, Novartis AG ADR, Merck KGaA, Roche Holding AG, GlaxoSmithKline, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account